Short answer: no. NAD+ is the molecule your cells use for energy and repair. NMN is one step earlier: it is the raw material cells turn into NAD+. The two are sold side by side and described in almost the same words, so it helps to know the difference before you read the research or choose one.
NAD+ vs NMN in 60 seconds
- NAD+ is the coenzyme itself, found in every cell. NMN is a precursor, one step before it.
- Cells turn NMN into NAD+ in a single reaction.
- Neither is a peptide. Both are small molecules, so doses are in hundreds of milligrams, not micrograms.
- NMN has a few small human trials, mostly oral. NAD+ is best known from slow IV drips at clinics.
- The research does not show that either one is better.
The short version
NAD+ (nicotinamide adenine dinucleotide) is the coenzyme itself. NMN (nicotinamide mononucleotide) is the building block cells use to make it.

| NAD+ | NMN | |
|---|---|---|
| Full name | Nicotinamide adenine dinucleotide | Nicotinamide mononucleotide |
| What it is | The coenzyme itself, in every cell | A precursor, one enzyme step before NAD+ |
| A peptide? | No, a small molecule | No, a small molecule |
| Human research | Best known from slow IV infusions at clinics | A handful of small, mostly oral trials from the 2020s |
| Our options | NAD+ 1000mg self-mix vial and 1000mg pen | NMN 1500mg pen and NMN capsules |
Why anyone cares about NAD+
NAD+ has two jobs. The first is energy: every time a cell turns food into usable energy, NAD+ carries the electrons. The second is as fuel for repair enzymes, including the sirtuins and the PARP enzymes that fix damaged DNA. Those enzymes use NAD+ up.
In animals and in several human tissues, NAD+ levels fall with age. One reason is an enzyme called CD38, which breaks NAD+ down and becomes more active as we get older. That decline is why people are interested: if levels fall with age, does raising them do anything useful?
Worth sitting with. Levels falling with age does not prove that topping them up helps. That is the question the current trials are trying to answer.
The precursor argument
NAD+ is a fairly large molecule and does not pass easily into cells in one piece. Much of it is broken down outside the cell into smaller pieces, including NMN, which cells take up and rebuild into NAD+. That is the case for going straight to a precursor.
Researchers are still mapping the exact route. A dedicated NMN transporter was reported in mice in 2019, but other researchers published a rebuttal the same year and the question is still debated. Either way, both routes end in the same place: more raw material for the body to make NAD+.
What the human research shows
- NMN has a handful of small human trials, mostly oral and mostly from the 2020s. They generally show it is well tolerated and raises NAD+ levels in the blood. The most quoted result is a 2021 study in 25 postmenopausal women with prediabetes: 250mg a day for ten weeks improved insulin sensitivity in muscle.
- NAD+ is best known from IV drips at clinics. They are run slowly because a fast infusion commonly causes flushing, nausea and chest tightness.
- For both, raising NAD+ levels is the first thing researchers measure. The longer-term questions about ageing are what the current wave of trials is working on.
What the options cost
Our NAD+ and NMN options
- NAD+ 1000mg self-mix vial from Noventra Pharma: R1,060, with bacteriostatic water in the box.
- NAD+ 1000mg pen from Peptide Pen: R890. Pre-filled, 240 clicks at about 4.2mg each, six sterile needles in the box.
- NMN 1500mg pen from Peptide Pen: R780. Pre-filled, 240 clicks at about 6.25mg each, six sterile needles in the box.
- NMN capsules, 60 from Limitless Performance: R710. 1,000mg a serving, 30 servings, no needles.
The NAD+ pen costs less than the NAD+ vial for the same 1000mg, which is unusual. Peptide pens vs self-mix vials explains where pens win on price and where they do not.
Commonly researched alongside
NAD+ and NMN come up in the same protocols as the mitochondrial peptides MOTS-c and SS-31, and alongside glutathione. They are grouped together because they are all studied around cellular energy, not because the combination has been shown to work.
NAD+ vs NMN: questions
Is NMN the same as NAD+?
No. NAD+ is the coenzyme cells use. NMN is a precursor that cells convert into NAD+ in a single enzyme step.
Which is better, NAD+ or NMN?
The research does not show that either is better. NMN has a handful of small human trials, mostly oral. NAD+ is best known from slow IV infusions at clinics.
Is NMN a peptide?
No. Neither NMN nor NAD+ is a peptide. Both are small molecules, which is why they are measured in hundreds of milligrams rather than micrograms.
What does CD38 do?
CD38 is an enzyme that breaks NAD+ down. It becomes more active with age in some tissues, which is one reason NAD+ levels fall.
Do you sell NAD+ and NMN in South Africa?
Yes. We list an NAD+ 1000mg self-mix vial, an NAD+ 1000mg pen, an NMN 1500mg pen and NMN capsules, all supplied for research use only. See the product pages for current prices.
Sources
- Yoshino M et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science, 2021 (25 postmenopausal women, 250mg a day for ten weeks). University summary.
- Grozio A et al. Slc12a8 is a nicotinamide mononucleotide transporter. Nature Metabolism, 2019, and the rebuttal by Schmidt MS and Brenner C, Absence of evidence that Slc12a8 encodes a nicotinamide mononucleotide transporter. Nature Metabolism, 2019.
Reading the studies yourself? How to read a peptide study without a science degree shows what to look for, and why a mouse result is not a human one.
Everything we supply is for research use only and is not a registered medicine. Nothing here is medical advice.
Browsing by goal? See peptides for energy and peptides for longevity.
More on the same theme: the peptide cheat sheet, MOTS-c and SS-31 and what peptides are.

